Top

International Urogynecology Journal

Published in:

01-05-2018 | Original Article

Opportunistic salpingectomy during vaginal hysterectomy for a benign pathological condition

Authors: Gery Lamblin, Capucine Meysonnier, Stéphanie Moret, Béatrice Nadaud, Georges Mellier, Gautier Chene

Published in: International Urogynecology Journal | Issue 5/2018

Abstract

Introduction and hypothesis

The objective was to evaluate the surgical feasibility of opportunistic salpingectomy or salpingo-oophorectomy during benign vaginal hysterectomy (HV) and the prevalence of occult tubal lesions.

Methods

In this prospective study from 1 September 2013 to 1 November 2015, the prevalence of bilateral salpingectomy with or without ovariectomy and the prevalence of histopathological and immunohistochemical tubal abnormalities were assessed.

Results

A total 115 patients were included. Bilateral salpingectomy was performed in 85 patients (73.92%; group A) and was technically impossible in 30 patients (26.08%; group B). Older patients (62.9 vs 57.5 years, p = 0.009), menopausal status (83.33% vs 62.35%, p = 0.03) and elevated BMI (27.58 vs 25.05 p = 0.03) were statistically associated with failure of salpingectomy. There was only one case of postoperative hemorrhage in group A. There was no difference with regard to intra- or postoperative complications, blood loss, and operating time between the two groups. Among the 67 fallopian tubes analyzed with a validated histopathological protocol, there were 8 (11.94%) immunohistochemical abnormalities with a “p53 signature.”

Conclusions

With the recent demonstration of a tubal origin of most ovarian cancer, opportunistic salpingectomy could be a theoretically relevant prevention strategy. Bilateral salpingectomy could be performed during benign vaginal hysterectomy by experienced surgeons. The advantages and disadvantages of exclusive salpingectomy during pelvic floor surgery should be discussed with the patients.

Chene G, Rahimi K, Mes-Masson AM, Provencher D. Surgical implications of the potential new tubal pathway for ovarian carcinogenesis. J Minim Invasive Gynecol. 2013;20:153–9.CrossRefPubMed

Oliver Perez MR, Magrina J, Garcia AT, Jimenez Lopez JS. Prophylactic salpingectomy and prophylactic salpingooophorectomy for adnexal high-grade serous epithelial carcinoma: a reappraisal. Surg Oncol. 2015;24:335–44.CrossRefPubMed

Walker JL, Powell CB, Chen LM, Carter J, Bae Jump VL, Parker LP, et al. Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer. Cancer. 2015;121:2108–20.

Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 2006;30:230–6.CrossRefPubMed

Chene G, Meysonnier C, Buenerd A, Moret S, Beaufils E, Le Bail-Carval K, et al. Feasibility of opportunistic salpingectomy at the time of vaginal hysterectomy for benign pathology and evaluation of occult tubal lesions prevalence: preliminary study. J Gynecol Obstet Biol Reprod (Paris). 2016;45:549–58.

Davies A, O’Connor H, Magos AL. A prospective study to evaluate oophorectomy at the time of vaginal hysterectomy. Br J Obstet Gynaecol. 1996;103:915–20.CrossRefPubMed

Kovac SR, Barhan S, Lister M, Tucker L, Bishop M, Das A. Guidelines for the selection of the route of hysterectomy : application in a resident clinic population. Am J Obstet Gynecol. 2002;187:1521–7.CrossRefPubMed

Muller CY, Coleman RL, Toler K, Gibbons D, Ashfaq R, Voet RL. Adequacy of oophorectomy at the time of gynecologic surgery. Int J Gynaecol Obstet. 2002;77:23–9.CrossRefPubMed

Bogani G, Cromi A, Serati M, Di Naro E, Casarin J, Pinelli C, et al. Laparoscopic and vaginal approaches to hysterectomy in the obese. Eur J Obstet Gynecol Reprod Biol. 2015;189:85–90.

10.

Karp DR, Mukati M, Smith AL, Suciu G, Aguilar VC, Davila GW. Predictors of successful salpingo-oophorectomy at the time of vaginal hysterectomy. J Minim Invasive Gynecol. 2012;19:58–62.CrossRefPubMed

11.

Cho HY, Kang SW, Kim HB, Park SH, Park ST. Prophylactic adnexectomy along with vaginal hysterectomy for benign pathology. Arch Gynecol Obstet. 2012;286:1221–5.CrossRefPubMed

12.

Sheth SS. Adnexectomy for benign pathology at vaginal hysterectomy without laparoscopic assistance. Br J Obstet Gynaecol. 2002;109:1401–5.CrossRef

13.

Robert M, Cenaiko D, Sepandj J, Iwanicki S. Success and complications of salpingectomy at the time of vaginal hysterectomy. J Minim Invasive Gynecol. 2015;22:864–9.CrossRefPubMed

14.

Chene G, de Rochambeau B, Le Bail-Carval K, Beaufils E, Chabert P, Mellier G, et al. Current surgical practice of prophylactic and opportunistic salpingectomy in France. Gynecol Obstet Fertil. 2016;44:377–84.

15.

Rabban JT, Garg K, Crawford B, Chen LM, Zaloudek CJ. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery. Am J Surg Pathol. 2014;38:729–42.CrossRefPubMed

16.

Mehrad M, Ning G, Chen EY, Mehra KK, Crum CP. A pathologist’s road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube. Adv Anat Pathol. 2010;17:293–302.CrossRefPubMed

17.

McAlpine JN, Hanley GE, Woo MM, Tone AA, Rozenberg N, Swenerton KD, et al. Ovarian cancer research program of British Columbia. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention. Am J Obstet Gynecol. 2014;210:471.e1–11.

18.

Kapurubandara S, Qin V, Gurram D, Anpalagan A, Merkur H, Hogg R, et al. Opportunistic bilateral salpingectomy during gynaecological surgery for benign disease: a survey of current Australian practice. Aust NZ J Obstet Gynaecol. 2015;55:606–11.

19.

Parker WH, Broder MS, Chang E, et al. Ovarian conservation at the time of hysterectomy and long term health outcomes in the nurses health study. Obstet Gynecol. 2010;113:1027–37.CrossRef

20.

Dwyer PL. Ovarian cancer and the pelvic floor surgeon: the case for prophylactic bilateral salpingectomy during POP surgery. Int Urogynecol J. 2012;23:655–6.CrossRefPubMed

21.

Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol. 2005;106:219–26.CrossRefPubMed

22.

Chene G, Lamblin G, Marcelli M, Huet S, Gauthier T. Urinary, infectious and digestive adverse events related to benign hysterectomy and the associated surgery on the fallopian tube: guidelines. J Gynecol Obstet Biol Reprod. 2015;44:1183–205.CrossRef

23.

Repasy I, Lendvai V, Koppan A, Bodis J, Koppan M. Effect of the removal of the fallopian tube during hysterectomy on ovarian survival: the orphan ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2009;144:64–7.CrossRefPubMed

24.

Ghezzi F, Cromi A, Siesto G, Bergamini V, Zefiro F, Bolis P. Infectious morbidity after total laparoscopic hysterectomy: does concomitant salpingectomy make a difference? BJOG. 2009;116:589–93.CrossRefPubMed

25.

Morse AN, Hammer RA, Walter AJ, Baker S, Magtibay PM. Does hysterectomy without adnexectomy in patients with prior tubal interruption increase the risk of subsequent hydrosalpinx? Am J Obstet Gynecol. 2002;187:1483–6.CrossRefPubMed

26.

Vorwerg J, Radosa MP, Nicolaus K, Baus N, Jimenez Cruz J, Rengsberger M, et al. Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and reoperation rate. J Cancer Res Clin Oncol. 2014;140:859–65.

27.

Venturella R, Lico D, Borelli M, Imbrogno MG, Cevenini G, Zupi E, et al. 3 to 5 years later: long-term effects of prophylactic bilateral salpingectomy on ovarian function. J Minim Invasive Gynecol. 2017;24:145–50.

28.

Yoon SH, Kim SN, Shim SH, Kang SB, Lee SJ. Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: a meta-analysis. Eur J Cancer. 2016;55:38–46.CrossRefPubMed

29.

Darelius A, Lycke M, Kindblom JM, Kristjansdottir B, Sundfeldt K, Strandell A. Efficacy of salpingectomy at hysterectomy to reduce the risk of epithelial ovarian cancer: a systematic review. BJOG. 2017;124:880–9.CrossRefPubMed

Title: Opportunistic salpingectomy during vaginal hysterectomy for a benign pathological condition
Authors: Gery Lamblin
Capucine Meysonnier
Stéphanie Moret
Béatrice Nadaud
Georges Mellier
Gautier Chene
Publication date: 01-05-2018
Publisher: Springer London
Published in: International Urogynecology Journal / Issue 5/2018
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-017-3418-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Opportunistic salpingectomy during vaginal hysterectomy for a benign pathological condition

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2018

Dynamic 3T pelvic floor magnetic resonance imaging in women progressing from the nulligravid to the primiparous state

Vaginal laxity: what does this symptom mean?

Increasing importance of research metrics: Journal Impact Factor and h-index

Physiotherapy for pelvic pain and female sexual dysfunction: an untapped resource

Strengthening validity in studies of pelvic floor disorders through qualitative research: an example from Ethiopia

Urogynaecology providers’ attitudes towards postnatal pelvic floor dysfunction